The Pathogenesis and Characterization of Oral Mucositis Associated with Cancer Therapy

Marylin Dodd

ONF 2004, 31(4), 5-11. DOI: 10.1188/04.ONF.S4.5-11

Purpose/Objectives: To describe the current knowledge about the pathogenesis of oral mucositis associated with cancer therapy and oral mucositis.

Jump to a section

    References

    Beck, S.L. (1999). Mucositis. In C.H. Yarbro, M.H. Frogge, & M. Goodman (Eds.), Cancer symptom management (2nd ed., pp. 328-343). Sudbury, MA: Jones and Bartlett.

    Eilers, J. (2001). When the mouth tells us more than it says—The impact of mucositis on quality of life. Oncology Supportive Care Quarterly, 1, 31-42.

    Eilers, J., Berger, A.M., & Petersen, M.C. (1988). Development, testing, and application of the Oral Assessment Guide. Oncology Nursing Forum, 15, 325-330.

    Hall, P.D., Benko, H., Hogan, K.R., & Stuart, R.K. (1995). The influence of serum tumor necrosis factor-alpha and interleukin-6 concentrations on nonhematologic toxicity and hematologic recovery in patients with acute myelogenous leukemia. Experimental Hematology, 23, 1256-1260.

    Kanety, H., Hem, R., Papa, M.Z., & Karasik, A. (1996). Sphingomyelinase and ceramide suppress insulin-induced tyrosine phosphorylation of the insulin receptor substrate-1. Journal of Biological Chemistry, 271, 9895-9897.

    Kaplow, R. (2001). Special nursing considerations. Critical Care Clinics, 17, 769-789.

    Khan, S.A., & Wingard, J.R. (2001). Infection and mucosal injury in cancer treatment. Journal of the National Cancer Institute Monographs, 29, 31-36.

    Kolesnick, R. (2002). The therapeutic potential of modulating the ceramide/ sphingomyelin pathway. Journal of Clinical Investigation, 110(1), 3-8.

    Kostler, W.J., Hejna, M., Wenzel, C., & Zielinski, C.C. (2001). Oral mucositis complicating chemotherapy and/or radiotherapy options for prevention and treatment. CA: A Cancer Journal for Clinicians, 51, 290-315.

    McGuire, D.B. (2002). Mucosal tissue injury in cancer therapy: More than mucositis and mouthwash. Cancer Practice, 10, 179-191.

    McGuire, D.B., Peterson, D.E., Muller, S., Owen, D.C., Slemmons, M.F., & Schubert, M.M. (2002). The 20 item Oral Mucositis Index: Reliability and validity in bone marrow and stem cell transplant patients. Cancer Investigation, 20, 893-903.

    National Cancer Institute. (1998). Cancer therapy evaluation program. Common Toxicity Criteria version 2.0. Bethesda, MD: Author.

    National Cancer Institute. (2003). Oral complications of chemotherapy and head/neck radiation. Retrieved July 7, 2003, from http://www.cancer.gov/cancerinfo/pdq/supportivecare/oralcomplications/HealthProfessional

    Peterson, D.E. (1999). Research advances in oral mucositis. Current Opinion in Oncology, 11, 261-266.

    Pico, J.L., Avila-Garavito, A., & Naccache, P. (1998). Mucositis: Its occurrence, consequences, and treatment in the oncology setting. Oncologist, 3, 446-451.

    Rabinowitz, J., Petros, W.P., Stuart, A.R., & Peters, W.P. (1993). Characterization of endogenous cytokine concentrations after high-dose chemotherapy with autologous bone marrow support. Blood, 81, 2452-2459.

    Shih, A., Miaskowski, C., Dodd, M.J., Stotts, N.A., & MacPhail, L. (2003). Mechanisms for radiation-induced oral mucositis and the consequences. Cancer Nursing, 26, 222-229.

    Smith, T. (2001). Gelclair: Managing the symptoms of oral mucositis. Hospital Medicine, 62, 623-626.

    Sonis, S.T. (1998). Mucositis as a biological process: A new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncology, 34(1), 39-43.

    Sonis, S.T. (2003. June). The pathobiology of mucositis. Paper presented at the annual meeting of the American Society of Clinical Oncology, Chicago, IL.

    Sonis, S.T., Eilers, J.P., Epstein, J.B., LeVeque, F.G., Liggett, W.H., Mulagha, M.T., et al. (1999). Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Cancer, 85, 2103-2113.

    Sonis, S.T., O'Donnell, K.E., Popat, R., & Hwang, D. (2003 June). Inhibition of ceramide synthase, but not sphingomyelinase attenuates radiation-induced mucositis in hamsters. Paper presented at the annual meeting of the American Society of Clinical Oncology, Chicago, IL.

    Sonis, S.T., Oster, G., Fuchs, H., Bellm, L., Bradford, W.Z., Edelsberg, J., et al. (2001). Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. Journal of Clinical Oncology, 19, 2201-2205.

    Sonis, S.T., Peterson, R.L., Edwards, L.J., Lucey, C.A., Wang, L., Mason, L., et al. (2000). Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters. Oral Oncology, 36, 373-381.

    Sonis, S.T., Scherer, J., Phelan, S., Lucey, C.A., Barron, J.E., O'Donnell, K.E., et al. (2002). The gene expression sequence of radiated mucosa in an animal mucositis model. Cell Proliferation, 35(Suppl. 1), 93-102.

    Squier, C.A., & Kremer, M.J. (2001). Biology of oral mucosa and esophagus. Journal of the National Cancer Institute Monographs, 29, 7-15.

    Trotti, A., Bellm, L.A., Epstein, J.B., Frame, D., Fuchs, H.J., Gwede, C.K., et al. (2003). Mucositis incidence, severity, and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: A systematic literature review. Radiotherapy Oncology, 66, 253-262.

    Wilkes, J.D. (1998). Prevention and treatment of oral mucositis following cancer chemotherapy. Seminars in Oncology, 25, 538-551.